A six-gene leukemic stem cell score identifies high risk pediatric acute myeloid leukemia
- 1 March 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Leukemia
- Vol. 34 (3), 735-745
- https://doi.org/10.1038/s41375-019-0604-8
Abstract
Recently, mRNA-expression signature enriched in LSCs was used to create a 17-gene leukemic stem cell (LSC17) score predictive of prognosis in adult AML. By fitting a Cox-LASSO regression model to the clinical outcome and gene-expression levels of LSC enriched genes in 163 pediatric participants of the AML02 multi-center clinical trial (NCT00136084), we developed a six-gene LSC score of prognostic value in pediatric AML (pLSC6). In the AML02 cohort, the 5-year event-free survival (EFS) of patients within low-pLSC6 group (n = 97) was 78.3 (95% CI = 70.5-86.9%) as compared with 34.5(95% CI = 24.7-48.2 %) in patients within high-pLSC6 group (n = 66 subjects), p < 0.00001. pLSC6 remained significantly associated with EFS and overall survival (OS) after adjusting for induction 1-MRD status, risk-group, FLT3-status, WBC-count at diagnosis and age. pLSC6 formula developed in the AML02 cohort was validated in the pediatric AML-TARGET project data (n = 205), confirming its prognostic value in both single-predictor and multiple-predictor Cox regression models. In both cohorts, pLSC6 predicted outcome of transplant patients, suggesting it as a useful criterion for transplant referrals. Our results suggest that pLSC6 score holds promise in redefining initial risk-stratification and identifying poor risk AML thereby providing guidance for developing novel treatment strategies.This publication has 25 references indexed in Scilit:
- Stem cell gene expression programs influence clinical outcome in human leukemiaNature Medicine, 2011
- AAML03P1, a pilot study of the safety of gemtuzumab ozogamicin in combination with chemotherapy for newly diagnosed childhood acute myeloid leukemiaCancer, 2011
- Gene expression profiling in the leukemic stem cell-enriched CD34+ fraction identifies target genes that predict prognosis in normal karyotype AMLLeukemia, 2011
- Association of a Leukemic Stem Cell Gene Expression Signature With Clinical Outcomes in Acute Myeloid LeukemiaJama-Journal Of The American Medical Association, 2010
- Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: results of the AML02 multicentre trialThe Lancet Oncology, 2010
- Identification of trypsin‐inhibitory site and structure determination of human SPINK2 serine proteinase inhibitorProteins-Structure Function and Bioinformatics, 2009
- Avoiding infinite estimates of time-dependent effects in small-sample survival studiesStatistics in Medicine, 2008
- High Stem Cell Frequency in Acute Myeloid Leukemia at Diagnosis Predicts High Minimal Residual Disease and Poor SurvivalClinical Cancer Research, 2005
- Gene expression profiling of pediatric acute myelogenous leukemiaBlood, 2004
- [Bootstrap Methods for Standard Errors, Confidence Intervals, and Other Measures of Statistical Accuracy]: RejoinderStatistical Science, 1986